Yuri Gelfand, M.D.

6% fewer Medicare Part D claims than the average otolaryngology physician in 2024

506 Medicare Part D claims for 201 beneficiaries, against an average of 536 among the 7,899 providers of this specialty who prescribed in Part D. Brand-name drugs were 8% of claims. 11 claims were for opioids.

Most prescribed

1. Methylprednisolone49 claims
2. Pantoprazole Sodium42 claims
3. Prednisone37 claims
4. Fluticasone Propionate36 claims
5. Ipratropium Bromide32 claims
6. Ciprofloxacin-Dexamethasone29 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's Medicare quality score for 2023: 100 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $195.43

8 payments, mostly food and beverage; the largest payer was Acera Surgical, Inc.. The 6,168 providers of this specialty with any payment received $2,038.17 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

One hospital or facility affiliation

1. Medical Center Ear, Nose And Throat Associates OF Houston, PLLCHouston, TX

Source: CMS Doctors and Clinicians affiliations; Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.